Photo by Wirestock
The New York State Cannabis Control Board convened on Dec. 18, 2025, closing out a consequential period for the state’s adult-use cannabis program. The board examined unresolved tensions around licensing pace, equity implementation, regulatory burden, and agency transparency. The meeting, chaired by Jessica Garcia, combined routine approvals with pointed debate, an extensive public comment session, and forward-looking signals tied to federal cannabis rescheduling and New York’s seed-to-sale rollout.
Leadership Transition and Tone-Setting
Garcia opened the meeting by acknowledging a leadership transition at the Office of Cannabis Management (OCM). She thanked Susan Filburn for stepping in as acting executive director, emphasizing continuity, transparency, and the Board’s expectation that regulatory rigor be paired with clearer communication to licensees and municipalities. The framing underscored a dual mandate that would recur throughout the meeting: sustaining market momentum while correcting process gaps that stakeholders say have become financially destabilizing.
License Approvals and Pipeline Status
The Board approved 38 adult-use licenses that had cleared the multi-step review process. The cohort included two cultivators, 10 retail dispensaries, five microbusinesses, four distributors, 13 processors, and four CAURD licenses, bringing the statewide total to 2,063 approved adult-use licenses. Patrick McCage of OCM provided a detailed snapshot of the application pipeline, highlighting both progress and attrition.
From the November application queue of 1,603 submissions, 751 received final licenses. Two hundred and forty three remained provisional, and 213 were pending examiner review. Another 386 had been closed through denial, withdrawal, or voiding. The December queues remained substantial, particularly on the retail side, with more than 2,700 retail dispensary applications still pending, alongside hundreds of microbusiness, cultivation, processing, and distribution applications. The numbers reinforced tension voiced later by the public: approval volume is rising, but not evenly across license types.
CAURD Renewals and Community Impact Expectations
Resolution 2025-88 addressed 16 Conditional Adult-Use Retail Dispensary renewals. Board members used the item to preview forthcoming guidance on community impact plans, a requirement that has lacked clarity during the program’s early years. OCM staff confirmed that they would publish written guidance immediately, outlining expectations around target populations, methods, and measurable outcomes. Renewing CAURD licensees will be required to review and submit plans consistent with that guidance before final renewal approval. This signals a more structured approach to equity accountability.
Amendments, Location Changes, and PCA Scrutiny
The Board approved 31 license and permit amendment requests, followed by a registered organization location change. The change authorized a new cultivation and manufacturing facility in Utica and a medical-only dispensary in Rensselaer County.
More contentious were the public convenience and advantage (PCA) determinations. Several applicants sought PCA relief for non-viable or proximity-conflicted locations under pre-November 2025 rules. In Plattsburgh and Cheektowaga, the Board denied requests where proposed locations would cluster near existing dispensaries, particularly those owned by social and economic equity (SEE) licensees. Board members expressed concern that approvals would undercut equity goals by intensifying competition in already saturated micro-markets.
Two additional PCA matters, involving Brooklyn and Flushing, were tabled due to unresolved documentation discrepancies. This included inconsistent ownership disclosures and lease questions. The decisions reflected a more cautious posture toward location-based waivers and a willingness to delay approvals with incomplete records.
Administrative Appeal and Procedural Boundaries
The Board unanimously dismissed an administrative appeal by Wicked Glass. OCM counsel emphasized that the appeal challenged a non-final ruling and was therefore premature. The decision reinforced the Board’s limited appellate authority and its reliance on a complete factual record before intervening.
OCM Report: Metrics, Money, and Momentum
In her report, Acting Executive Director Susan Filburn highlighted enforcement progress against illicit operators, the opening of the state’s 500th adult-use dispensary, and the rollout of the statewide seed-to-sale system. OCM confirmed that Metrc would provide 20 million universal identification tags at no cost to processors and that retailers would have until January 12 to enter existing inventory, extending the transition to avoid holiday-season disruptions.
Data scientist John Kagia’s market update quantified the industry’s rapid expansion. New York is on pace to close 2025 with approximately $1.65 billion in adult-use sales, double the prior year, and $2.6 billion since launch. Data presented showed falling prices across most product categories, particularly beverages, alongside stabilizing average retail revenues as store counts increased. The analysis framed price compression as a sign of maturation rather than distress, though Kagia noted the need for close monitoring.
Kakia also addressed anticipated federal action to reschedule cannabis from Schedule I to Schedule III. While not yet finalized, the shift would likely eliminate Internal Revenue Code Section 280E. This may potentially reduce federal tax burdens by 30-75% for cannabis businesses. He cautioned that rescheduling would not legalize interstate commerce or automatically resolve banking barriers. But, he described it as the most significant federal policy change in decades.
Equity Metrics and Data Gaps
OCM’s equity update reported that 57% of all adult-use licenses are held by SEE-certified entities, with particularly high representation in retail. Minority-owned businesses accounted for roughly half of licenses, and women-owned businesses for more than half. Smaller but growing shares were attributed to distressed farmers and service-disabled veterans. Board members emphasized that aggregate percentages obscure uneven outcomes across the supply chain and called for more granular impact analysis.
Public Comment: Pressure Points Laid Bare
The meeting’s public comment session, with 27 speakers across Albany, Buffalo, and New York City, dominated the latter half of the agenda. Cultivators warned of a prolonged slowdown in approvals, arguing that fears of oversupply ignore the scale of illicit diversion and federally legal hemp-derived THC products entering the state. Microbusinesses and farmers repeatedly criticized proposed growers’ showcase regulations that would exclude micros from direct-to-consumer sales at events. They contended that such restrictions undermine the MRTA’s intent and their financial viability.
Multiple speakers raised alarms about the seed-to-sale rollout. They were particularly concerned about the cost and logistics of per-unit retail ID tags, which small operators say disproportionately burden low-priced products and favor large-scale producers. Others cited delayed responses from OCM, conflicting municipal requirements, and months of carrying rent and payroll without clarity on opening timelines.
Several commenters went further. They alleged systemic bias, regulatory overreach, and uneven enforcement, while urging the Board to restore trust through clearer rules, consistent application, and earlier stakeholder engagement.
Closing the Year with Unresolved Questions
The meeting closed with routine adjournment. But the substance of the discussion suggested that 2026 will open with heightened scrutiny of how New York balances growth, equity, and administrative capacity. The Board signaled openness to revisiting processes for PCA requests, unreasonable impracticability determinations, and community impact enforcement. Yet the volume and intensity of public testimony made clear that many licensees see regulatory uncertainty, not market demand, as the primary risk to survival.
As New York enters its next phase of legalization, a critical question remains. Can the state maintain rapid expansion while ensuring that small operators and equity licensees can endure the costs of compliance to benefit from the market they helped create?
Leave a Reply